Sunny Pharmtech Inc. (6676.TWO)
TWD 14.45
(0.7%)
TWD 14.45
(0.7%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -63.32 Million TWD | 62.81% |
| 2022 | -170.24 Million TWD | 2.6% |
| 2021 | -174.79 Million TWD | -71.77% |
| 2020 | -101.76 Million TWD | 55.03% |
| 2019 | -226.29 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -19.64 Million TWD | 0.0% |
| 2024 Q1 | -19.64 Million TWD | -251.14% |
| 2023 Q1 | -26.06 Million TWD | 18.36% |
| 2023 Q3 | -5.59 Million TWD | 78.54% |
| 2023 FY | -63.32 Million TWD | 62.81% |
| 2023 Q4 | -5.59 Million TWD | 0.0% |
| 2023 Q2 | -26.06 Million TWD | 0.0% |
| 2022 Q3 | -31.92 Million TWD | 0.0% |
| 2022 FY | -170.24 Million TWD | 2.6% |
| 2022 Q4 | -31.92 Million TWD | 0.0% |
| 2021 FY | -174.79 Million TWD | -71.77% |
| 2020 FY | -101.76 Million TWD | 55.03% |
| 2019 FY | -226.29 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 125.226% |
| Level Biotechnology Inc. | 62.9 Million TWD | 200.66% |
| Sagittarius Life Science Corp | -55.03 Million TWD | -15.046% |
| NeoCore Technology Co., Ltd. | -64.64 Million TWD | 2.05% |
| TaiMed Biologics Inc. | -194.81 Million TWD | 67.497% |
| GlycoNex Incorporation | -178.36 Million TWD | 64.499% |
| VBI | -6.6 Million TWD | -859.249% |
| GeneReach Biotechnology Corp. | -166.27 Million TWD | 61.917% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | -492.773% |
| Visgeneer Inc. | -19.58 Million TWD | -223.243% |
| Mycenax Biotech Inc. | -682.84 Million TWD | 90.727% |
| Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 110.12% |
| G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 187.459% |
| Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 94.541% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | -947.131% |
| Enimmune corporation | -223.74 Million TWD | 71.7% |
| TaiRx, Inc. | -212.29 Million TWD | 70.173% |
| CHO Pharma, Inc. | -306.08 Million TWD | 79.313% |
| EirGenix Inc. | -915.2 Million TWD | 93.081% |
| BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | 227.294% |
| Lin BioScience, Inc. | -687.19 Million TWD | 90.786% |
| BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | 59.495% |
| Feng Chi Biotech Corp. | 22.79 Million TWD | 377.817% |
| Bio Preventive Medicine Corp. | -73.28 Million TWD | 13.598% |
| Lukas Biomedical Inc. | -47.35 Million TWD | -33.719% |
| RBC Bioscience Corporation | 6.43 Million TWD | 1084.759% |
| BiOptic Inc. | 37.74 Million TWD | 267.748% |
| BRIM Biotechnology, Inc. | -688.02 Million TWD | 90.797% |
| Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | -70.375% |
| Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | -2.892% |
| Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 123.04% |
| Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | -22.282% |
| SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | -65.881% |
| Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | 62.324% |
| Neith Corporation | -40.03 Million TWD | -58.17% |
| Advagene Biopharma Co., Ltd. | -92.11 Million TWD | 31.256% |
| NaviFUS Corp. | -65.72 Million TWD | 3.665% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | 28.118% |
| Sinew Pharma Inc. | -170.92 Million TWD | 62.954% |
| Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | 7.1% |
| Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 148.46% |
| Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | 73.4% |
| AP Biosciences Inc | -339.29 Million TWD | 81.338% |
| Medigen Biotechnology Corp. | -561.29 Million TWD | 88.719% |
| 3D Global Biotech Inc. | -57.95 Million TWD | -9.265% |
| Pharmosa Biopharm Inc. | 8.45 Million TWD | 848.817% |
| Intech Biopharm Corporation | -337.98 Million TWD | 81.266% |
| Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 95.177% |
| Eusol Biotech Co.,Ltd. | -51.61 Million TWD | -22.682% |
| TWi Biotechnology, Inc. | -170.68 Million TWD | 62.902% |
| Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 111.739% |
| TCI GENE Inc. | 11.67 Million TWD | 642.448% |
| MegaPro Biomedical Co., Ltd | -127.54 Million TWD | 50.356% |
| Senhwa Biosciences, Inc. | -296.3 Million TWD | 78.63% |
| Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | 70.889% |
| NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | 725.692% |
| PharmaEngine, Inc. | 274.65 Million TWD | 123.055% |
| Savior Lifetec Corporation | 30.03 Million TWD | 310.856% |
| TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 146.31% |
| OBI Pharma, Inc. | -1.04 Billion TWD | 93.949% |
| Meribank Biotech Co., Ltd | -125.34 Million TWD | 49.484% |
| Acepodia, Inc. | -817.31 Million TWD | 92.253% |
| Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | 87.037% |